PATRUNO, CAROLA
 Distribuzione geografica
Continente #
EU - Europa 71
NA - Nord America 71
AS - Asia 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 160
Nazione #
US - Stati Uniti d'America 71
SE - Svezia 37
IT - Italia 18
CN - Cina 10
A1 - Anonimo 7
IE - Irlanda 6
FI - Finlandia 4
PT - Portogallo 3
DE - Germania 2
EU - Europa 1
FR - Francia 1
Totale 160
Città #
Ashburn 23
New York 10
Shanghai 9
Lawrence 8
Princeton 8
Dublin 6
Rome 6
Helsinki 4
Guarda 3
Milan 3
Washington 3
Giugliano in Campania 2
Seattle 2
Neuilly-sur-Seine 1
Osimo 1
Secaucus 1
Totale 90
Nome #
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 29
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 28
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 21
Diagnosis and management of moderate to severe atopic dermatitis in adolescents. A Consensus by the Italian Society of Dermatology and Venereology (SIDemaSt), the Italian association of Hospital Dermatologists and Public Health (aDoI), the Italian association of Hospital and territorial allergists and Immunologists (aaIIto), the Italian Society of allergy, asthma and Clinical Immunology (SIaaIC), the Italian Society of Pediatric allergy and Immunology (SIaIP), the Italian Society of allergological, occupational and environmental Dermatology (SIDaPa), and the Italian Society of Pediatric Dermatology (SIDerP) 15
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 14
Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: Recommendations from the Italian Society of Dermatology (SIDeMaST) 13
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study 13
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients 13
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 11
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response 9
Cutaneous reactions to analgesic- antipyretics and nonsteroidal anti-inflammatory drugs: Analysis of reports to the spontaneous reporting system of the gruppo italiano studi epidemiologici in dermatologia 5
Totale 171
Categoria #
all - tutte 1.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 0 0 0 0 0 15 0 1 0 0 0
2022/202376 18 14 7 0 8 11 5 3 4 3 1 2
2023/202479 3 0 13 17 9 19 4 10 4 0 0 0
Totale 171